Several investment firms, including Illinois Municipal Retirement Fund, New York Life, and Oppenheimer, have adjusted their holdings in companies like NV5 Global, Zillow, and Jazz Pharmaceuticals. Nebius expresses confidence in its AI potential. Read more...

Several institutional investors, including Mutual of America, Oppenheimer, and IFP Advisors, adjusted their holdings in various companies during the fourth quarter, according to Holdings Channel. Read more...

BYD, the leading Chinese EV manufacturer, has pledged to collaborate with Tesla to accelerate the transition away from gasoline-powered vehicles, citing Beijing's open approach to foreign business. Read more...

Rivian hits a milestone with its first gross profit, while Marvell disappoints investors. Plus, updates on Duolingo and MACOM Technology Solutions Holdings. Read more...

Zscaler's AI-driven growth, Burlington Stores' earnings beat, and analyst adjustments for Ready Capital are among the key market movers. Plus, a strategy for passive income. Read more...

Reddit's co-founder joins the TikTok acquisition race, while a digital bank offers incentives to curb social media use. Plus, a look at the Great Depression. Read more...

Several investment firms, including QRG Capital Management, Oppenheimer Asset Management, and Shoker Investment Counsel, adjusted their positions in assets like ETFs, Estée Lauder, and Meta Platforms during the last quarter. Litecoin also sees gains due to potential ETF. Read more...

Several institutional investors adjusted their portfolios in the fourth quarter, with notable moves involving Invesco, Flutter Entertainment, Robinhood, and others, according to recent SEC filings. Read more...

A look at recent investment news, including Brookfield Infrastructure's growth potential, a financial review of Magnera, and activity around stocks like Noah, Chemed, Advance Auto Parts, and Valvoline. Read more...

Several institutional investors adjusted their holdings in various companies during the fourth quarter, according to recent SEC filings. Key adjustments include stake increases in FTAI Aviation and QCR Holdings, and new positions in Meta. Read more...

A summary of recent business news, including an executive departure at Kroger and stock adjustments by Mutual of America and Oppenheimer Asset Management. Read more...

Several institutional investors, including Oppenheimer, Principal, and Rhumbline, adjusted their holdings in various companies during the fourth quarter, according to recent reports. Read more...

Recent reports show mixed performance for tech stocks. Nvidia faces headwinds, while BioVie and Bel Fuse see increased short interest. Olaplex maintains its rating. Read more...

Recent stock market activity sees varied ratings, with Humana and Pebblebrook Hotel Trust downgraded by StockNews.com, while Jones Lang LaSalle receives an upgrade. Oppenheimer also adjusts positions in Trupanion and Intapp. Read more...

A quick look at recent stock market activity, including movements for SKK Holdings, Krystal Biotech, Pennant Group, and comparative analyses for other companies. Read more...

Several firms adjusted their investment portfolios in Q4. Hardy Reed increased its stake in Alphabet, while Mutual of America Capital Management reduced its PVH holdings. Read more...

Recent SEC filings reveal institutional investors adjusting their holdings in major companies like Molson Coors, JPMorgan Chase, National Grid, and Walmart. Read more...

Several investment firms, including Mutual of America Capital Management and Oppenheimer Asset Management, adjusted their holdings in various companies during the fourth quarter. Read more...

The SEC revokes Surity Cash's license due to unfair practices, while firms like Fisher, Oppenheimer, and Twin Peaks adjust their holdings in Target, Banco Bradesco, and JPMorgan Chase. Read more...

Several investment firms, including Sage Investment Counsel, Bank OZK, Mutual of America, and Oppenheimer Asset Management, adjusted their holdings in companies like Meta, First American Financial, and Madrigal Pharmaceuticals during Q4. Read more...